Fuji Pharma Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuji Pharma Company Limited with three other
companies in this sector in Japan:
JCR Pharmaceuticals Co., Ltd.
sales of 17.44 billion Japanese Yen [US$156.42 million]
of which 98%
was Pharmaceutical Business),
Taiko Pharmaceutical Company., Limited
(8.33 billion Japanese Yen [US$74.70 million]
of which 73%
was Medicine Goods), and
Daito Pharmaceutical Company Limited
(36.37 billion Japanese Yen [US$326.24 million]
of which 60%
was Drug Substance).
Fuji Pharma Company Limited reported sales of ¥34.23 billion (US$307.03 million)
September of 2016.
increase of 8.0%
versus 2015, when the company's sales were ¥31.68 billion.
This was the fourth straight year of sales growth at Fuji Pharma Company Limited.